<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/18/medidata-solutions-inc-nasdaqmdso-receives-average-recommendation-of-hold-from-analysts.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-18T14:31:01+00:00"/>
    <meta property="og:title" content="Medidata Solutions Inc (NASDAQ:MDSO) Receives Average Recommendation of “Hold” from Analysts"/>
    <meta property="og:description" content="Shares of Medidata Solutions Inc (NASDAQ:MDSO) have earned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the company, MarketBeat reports. Ten investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokerages that have […]"/>
  </head>
  <body>
    <article>
      <h1>Medidata Solutions Inc (NASDAQ:MDSO) Receives Average Recommendation of “Hold” from Analysts</h1>
      <address><time datetime="2019-11-18T14:31:01+00:00">18 Nov 2019, 14:31</time> by <a rel="author" href="https://www.thecerbatgem.com/author/renee" target="_blank">Renee Jackson</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/medidata-solutions-inc-logo.png"/>
      </figure>
      <p>Shares of Medidata Solutions Inc (NASDAQ:MDSO) have earned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the company, <a href="https://www.marketbeat.com/">MarketBeat</a> reports. Ten investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $87.63.</p>
      <p>A number of research firms have recently issued reports on MDSO. BidaskClub raised Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, October 1st. <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> raised Medidata Solutions from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a report on Wednesday, October 23rd. Finally, <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=MDSO">ValuEngine</a> lowered Medidata Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd.</p>
      <p>A number of hedge funds have recently made changes to their positions in MDSO. Alpine Associates Management Inc. purchased a new stake in Medidata Solutions during the second quarter worth $130,872,000. Syquant Capital Sas boosted its position in Medidata Solutions by 348.5% during the third quarter. Syquant Capital Sas now owns 1,550,606 shares of the company’s stock worth $141,880,000 after purchasing an additional 1,204,864 shares in the last quarter. Magnetar Financial LLC purchased a new stake in Medidata Solutions during the second quarter worth $70,980,000. Assenagon Asset Management S.A. purchased a new stake in Medidata Solutions during the third quarter worth $50,333,000. Finally, Echo Street Capital Management LLC lifted its position in shares of Medidata Solutions by 82.3% in the second quarter. Echo Street Capital Management LLC now owns 1,044,848 shares of the company’s stock valued at $94,569,000 after acquiring an additional 471,628 shares in the last quarter. 93.30% of the stock is currently owned by hedge funds and other institutional investors.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/MDSO/price-target/">NASDAQ:MDSO</a> traded down $0.02 during trading on Monday, reaching $92.22. The company had a trading volume of 7,354,000 shares, compared to its average volume of 1,239,614. The firm has a market capitalization of $5.76 billion, a price-to-earnings ratio of 96.06, a price-to-earnings-growth ratio of 6.95 and a beta of 1.22. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.56 and a quick ratio of 2.56. The stock’s fifty day moving average price is $91.93 and its 200 day moving average price is $91.48. Medidata Solutions has a fifty-two week low of $60.10 and a fifty-two week high of $98.60.</p>
      <p>
        <b>About Medidata Solutions</b>
      </p>
      <p>Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.</p>
      <p>Further Reading: <a href="https://www.marketbeat.com/financial-terms/cost-of-equity-business-investors/">What is cost of equity?</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=MDSO"/>
      </figure>
    </article>
  </body>
</html>